Literature DB >> 15664972

Plasmodium falciparum merozoite surface protein 6 displays multiple targets for naturally occurring antibodies that mediate monocyte-dependent parasite killing.

Subhash Singh1, Soe Soe, Christian Roussilhon, Giampietro Corradin, Pierre Druilhe.   

Abstract

Plasmodium falciparum MSP6 is a merozoite surface antigen that shows organization and sequence homologies similar to those of MSP3. Within its C-terminus conserved region, it presents some epitopes that are cross-reactive with MSP3 and others that are not, both being targets of naturally occurring antibodies that block the P. falciparum erythrocytic cycle in cooperation with monocytes.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15664972      PMCID： PMC547023          DOI： 10.1128/IAI.73.2.1235-1238.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  18 in total

1.  Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys.

Authors:  Hajime Hisaeda; Allan Saul; Joshua J Reece; Michael C Kennedy; Carole A Long; Louis H Miller; Anthony W Stowers
Journal:  J Infect Dis       Date:  2002-02-14       Impact factor: 5.226

2.  Differential patterns of human immunoglobulin G subclass responses to distinct regions of a single protein, the merozoite surface protein 1 of Plasmodium falciparum.

Authors:  D R Cavanagh; C Dobaño; I M Elhassan; K Marsh; A Elhassan; L Hviid; E A Khalil; T G Theander; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

3.  Regulation of antigen-specific immunoglobulin G subclasses in response to conserved and polymorphic Plasmodium falciparum antigens in an in vitro model.

Authors:  Olivier Garraud; Ronald Perraut; Ababacar Diouf; Wilfrid S Nambei; Adama Tall; André Spiegel; Shirley Longacre; David C Kaslow; Hélène Jouin; Denise Mattei; Gina M Engler; Thomas B Nutman; Eleanor M Riley; Odile Mercereau-Puijalon
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein.

Authors:  Soe Soe; Michael Theisen; Christian Roussilhon; Khin-Saw Aye; Pierre Druilhe
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.

Authors:  Subhash Singh; Soe Soe; Juan-Pedro Mejia; Christian Roussilhon; Michael Theisen; Giampietro Corradin; Pierre Druilhe
Journal:  J Infect Dis       Date:  2004-07-27       Impact factor: 5.226

6.  Naturally acquired antibody responses to the components of the Plasmodium falciparum merozoite surface protein 1 complex.

Authors:  Lina Wang; Lucy Crouch; Thomas L Richie; Doan Hanh Nhan; Ross L Coppel
Journal:  Parasite Immunol       Date:  2003 Aug-Sep       Impact factor: 2.280

7.  Plasmodium falciparum merozoite surface protein 6 is a dimorphic antigen.

Authors:  J Andrew Pearce; Tony Triglia; Anthony N Hodder; David C Jackson; Alan F Cowman; Robin F Anders
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  A longitudinal study of human antibody responses to Plasmodium falciparum rhoptry-associated protein 1 in a region of seasonal and unstable malaria transmission.

Authors:  P N Fonjungo; I M Elhassan; D R Cavanagh; T G Theander; L Hviid; C Roper; D E Arnot; J S McBride
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

9.  The merozoite surface protein 6 gene codes for a 36 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex.

Authors:  C Trucco; D Fernandez-Reyes; S Howell; W H Stafford; T J Scott-Finnigan; M Grainger; S A Ogun; W R Taylor; A A Holder
Journal:  Mol Biochem Parasitol       Date:  2001-01-15       Impact factor: 1.759

10.  Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against Plasmodium falciparum.

Authors:  E Badell; C Oeuvray; A Moreno; S Soe; N van Rooijen; A Bouzidi; P Druilhe
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307
View more
  21 in total

1.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans.

Authors:  Corine G Demanga; Lena-Juliette Daher; Eric Prieur; Catherine Blanc; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-11-02       Impact factor: 3.441

2.  Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.

Authors:  Anja Jäschke; Boubacar Coulibaly; Edmond J Remarque; Hermann Bujard; Christian Epp
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

3.  Antibodies directed against merozoite surface protein-6 are induced by natural exposure to Plasmodium falciparum in a low transmission environment.

Authors:  S J Jordan; A L Oliveira; A T Neal; J N Hernandez; O H Branch; J C Rayner
Journal:  Parasite Immunol       Date:  2011-07       Impact factor: 2.280

4.  Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic properties.

Authors:  Rasmus Lundquist; Leif Kofoed Nielsen; Ali Jafarshad; Daw Soesoe; Lars Harder Christensen; Pierre Druilhe; Morten Hanefeld Dziegiel
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Limited variation in vaccine candidate Plasmodium falciparum Merozoite Surface Protein-6 over multiple transmission seasons.

Authors:  Aaron T Neal; Stephen J Jordan; Ana L Oliveira; Jean N Hernandez; Oralee H Branch; Julian C Rayner
Journal:  Malar J       Date:  2010-05-24       Impact factor: 2.979

6.  The C-terminal domain of Plasmodium falciparum merozoite surface protein 3 self-assembles into alpha-helical coiled coil tetramer.

Authors:  Claire Gondeau; Giampietro Corradin; Frédéric Heitz; Christian Le Peuch; Andrea Balbo; Peter Schuck; Andrey V Kajava
Journal:  Mol Biochem Parasitol       Date:  2009-02-10       Impact factor: 1.759

7.  Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models.

Authors:  Lena-Juliette Daher; Corine G Demanga; Eric Prieur; Jean-Louis Pérignon; Hasnaa Bouharoun-Tayoun; Pierre Druilhe
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

8.  Multiple Plasmodium falciparum Merozoite Surface Protein 1 Complexes Mediate Merozoite Binding to Human Erythrocytes.

Authors:  Clara S Lin; Alessandro D Uboldi; Christian Epp; Hermann Bujard; Takafumi Tsuboi; Peter E Czabotar; Alan F Cowman
Journal:  J Biol Chem       Date:  2016-01-28       Impact factor: 5.157

9.  Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs.

Authors:  Gilles Bang; Eric Prieur; Christian Roussilhon; Pierre Druilhe
Journal:  PLoS One       Date:  2011-12-01       Impact factor: 3.240

10.  A conserved multi-gene family induces cross-reactive antibodies effective in defense against Plasmodium falciparum.

Authors:  Subhash Singh; Soe Soe; Simon Weisman; John W Barnwell; Jean Louis Pérignon; Pierre Druilhe
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.